生命科学资讯

Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem'

Pfizer's oncology R&D strategy: Jeff Legos on speed, breadth and novel combinations

Alternative splicing strategy shows promise for Rett syndrome

Yale’s Craig Crews builds model to guide biotech startups out of academia’s ‘valley of death’

FDA's top operating official Butler to retire, deputy to take over in April

Roche announces $481m investment in South Korean biotech sector - Investment Monitor

Moderna to pay up to $2.25B to end mRNA vaccine patent fight

Sanofi licenses Sino Biopharm’s JAK/ROCK drug for $1.4B

China approves first noninvasive therapy for cervical precancer

Blackstone puts $400M into Teva, Sanofi gut disease drug

Thermo Fisher’s Candida Auris Test Launch Meets Valuation And Momentum Crossroads - simplywall.st

Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem' - Fierce Biotech

Prime to test FDA flexibility with 2-patient gene editing submission

Nvidia dives deeper into medtech, cancer research with Droplet Biosciences

ARPA-H launches $158M effort to aid first-ever lymphatic system medicines

Bayer tosses 1 Pompe gene therapy from $2B AskBio buyout to focus on alternative option

UK invests $64M to expand clinical trial access to underserved communities

Bayer continues trimming workforce; AnaptysBio's spinoff is named

BIO chief still backs FDA's Makary despite 'head-scratcher' decisions

Marc Casper sells 5,000 TMO shares via Fidelity (TMO) - Stock Titan